Harnessing the antibacterial and immunological properties of mucosal-associated invariant T cells in the development of novel oral vaccines against enteric infections-Reference-Cited by-同舟云学术

Harnessing the antibacterial and immunological properties of mucosal-associated invariant T cells in the development of novel oral vaccines against enteric infections

Published:2014-11 Issue:2 Volume:92 Page:173-183
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Abautret-Daly Aine E.^ORCID,Davitt Christopher J.H.,Lavelle Ed C.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference81 articles.

1. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000;Liu;Lancet,2012

2. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study;Kotloff;Lancet,2013

3. Mucosal adjuvants;Freytag;Vaccine,2005

4. Vaccines against mucosal infections;Holmgren;Curr Opin Immunol,2012

5. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens;Clements;Vaccine,1988

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines;BioDrugs;2023-01-06

2. Adjuvants, immunomodulators, and adaptogens;Vaccinology and Methods in Vaccine Research;2022

3. Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines;Vaccines;2021-06-08

4. Technological Approaches for Improving Vaccination Compliance and Coverage;Vaccines;2020-06-16

5. Natural killer T cell ligand alpha-galactosylceramide protects against gut ischemia reperfusion-induced organ injury in mice;Cytokine;2018-11